Digital Respiratory Devices Market Size to Reach $514.74 Billion by 2032 Driven by Rising Prevalence of Chronic Respiratory Diseases – SNS Insider
SNS Insider reports that the U.S. Digital Respiratory Devices Market is projected to expand from $25.90 billion in 2024 to $156.79 billion by 2032, reflecting rising investment in remote respiratory diagnostics, asthma and COPD management platforms, and clinical-grade home monitoring systems.
Austin, Nov. 26, 2025 (GLOBE NEWSWIRE) — Digital Respiratory Devices Market Size and Growth Outlook
According to SNS Insider, the global Digital Respiratory Devices Market size was valued at $72.69 billion in 2024 and is projected to reach $514.74 billion by 2032, registering a CAGR of 27.77% from 2025 to 2032.
Growth is fueled by increasing chronic respiratory disease prevalence, widespread adoption of sensor-enabled inhalers, integration of AI into respiratory diagnostics, and rapid expansion of home-based care.
Download PDF Brochure: https://www.snsinsider.com/sample-request/7563
The U.S. digital respiratory devices market is projected to grow from $25.90 billion in 2024 to $156.79 billion by 2032, at a CAGR of 25.27% during the same period.
In the United States, strong investments from medtech innovators, telehealth leaders, and hospital networks are accelerating the shift toward digital respiratory care. Globally, rising adoption of remote monitoring, expanded insurance reimbursements, and national programs targeting asthma and COPD are strengthening the market’s growth trajectory.
Key Digital Respiratory Devices Companies Profiled in the Report
- Philips Respironics
- ResMed Inc.
- Fisher and Paykel Healthcare
- Medtronic plc
- Drägerwerk AG and Co. KGaA
- 3M Health Care
- AptarGroup Inc.
- Cohero Health (Amiko Digital Health)
- Propeller Health
- Sensirion AG
- Other key industry participants
Get a Sample Report of Digital Respiratory Devices Market: https://www.snsinsider.com/sample-request/7563
Digital Respiratory Devices Market Report Scope
| Market Size in 2024 | $72.69 Billion |
| Market Size by 2032 | $514.74 Billion |
| CAGR | CAGR of 27.77% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Segmentation Analysis:
By Product
In 2024, the smart inhalers and nebulizers segment accounted for the largest market share in the digital respiratory device market, with 68.25% market share, owing to continuous application to manage chronic respiratory conditions such as asthma and COPD. Owing to increasing digitalization of healthcare and growing demand for consumer desire for self-monitoring tools, the Sensors and Apps segment is expected to grow fastest throughout the forecast years.
By Disease Indication
Due to the high global burden of COPD and the increasing geriatric population, the COPD segment held the largest share of the digital respiratory devices market in 2024, with a 54.2% market share. The asthma segment is expected to be the fastest-growing segment during the forecasting years due to its increasing prevalence around the globe, especially among children and young adults.
By Distribution Channel
The hospital pharmacies segment accounted led the digital respiratory devices market in 2024, with 70.2% market share, owing to the critical role of hospital pharmacies in the management of acute and chronic respiratory conditions in clinical settings. The fastest growth rate is expected from the retail pharmacy segment as end-use suppliers prefer retail pharmacies due to the convenience factor provided here and growing consumer preferences for innovative accessibility solutions.
By End-Use
The hospitals segment held the largest share of 46.12% of the digital respiratory devices market in 2024 as a large number of patients are admitted to hospitals for the treatment of moderate to severe respiratory diseases, such as COPD and asthma. Homecare settings are expected to show the fastest growth in the digital respiratory devices market throughout the forecast period, owing to high adoption of remote monitoring and patient-centric care.
Purchase Single User PDF of Digital Respiratory Devices Market Report: https://www.snsinsider.com/checkout/7563
Regional Insights:
North America contributed to the 48.08% market share in 2024. The highest share of North America in the global digital respiratory devices market is attributed to high healthcare infrastructure, awareness about digital health technologies, and a high volume of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD).
Due to rising healthcare spending, increasing patient awareness, and a rapidly growing geriatric population, Asia Pacific is the fastest-growing region of the digital respiratory devices market with a 28.74% CAGR.
Digital Respiratory Devices Market Segmentation
By Product
- Smart Inhalers and Nebulizers
- Sensors and Apps
By Disease Indication
- Asthma
- COPD
- Other Diseases
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By End Use
- Hospitals
- Homecare Settings
- Other Settings
Recent Developments:
- In April 2024, Medtronic launched its Touch Surgery Live Stream platform, an innovative solution that allows for the real-time streaming of laparoscopic and robotic-assisted surgical procedures. Now available in more than 20 countries, the platform aims to transform surgical education by optimizing remote training opportunities for medical professionals globally.
- In September 2024, ResMed, the world leader in sleep, respiratory care, and home healthcare technology, announced the release of new patient-focused innovations designed to enhance the therapy experience for people with sleep apnea. The new solutions feature digital wearable integration and generative AI to provide a more personalized and powerful sleep health experience, enabling better long-term outcomes.
Need Any Customization Research on Digital Respiratory Devices Market, Enquire Now: https://www.snsinsider.com/enquiry/7563
Exclusive Sections of the Report (The USPs):
- DISEASE BURDEN & PREVALENCE METRICS – helps you understand the rising incidence of asthma, COPD, and respiratory disorders across major regions, enabling better estimation of device demand and patient population growth.
- SMART INHALER & CONNECTED DEVICE ADOPTION INDEX – helps you track the penetration of Bluetooth-enabled inhalers, sensor-based add-ons, and integrated digital platforms, revealing technology readiness and adoption gaps across demographics.
- REMOTE MONITORING UTILIZATION SCORE – helps you identify regional disparities in digital respiratory monitoring—from North America’s high telehealth uptake to emerging markets’ gradual adoption—supporting investment decisions for digital care expansion.
- REIMBURSEMENT & HEALTHCARE SPENDING LANDSCAPE – helps you evaluate the impact of insurance coverage, payer policies, and digital therapeutic reimbursement models on device affordability and market scalability across regions.
- PATIENT ENGAGEMENT & COMPLIANCE TRACKING INSIGHTS – helps you assess how connected inhalers improve medication adherence, symptom tracking, and patient–clinician communication, offering insights into clinical performance and digital health ROI.
Related Reports
Smart Inhalers Market
Remote Patient Monitoring Market
Respiratory Care Devices Market
Home Healthcare Devices Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaEveningPost.com takes no editorial responsibility for the same.